tiprankstipranks
Advertisement
Advertisement

GB:POLB Stock Latest News

Poolbeg Pharma Publishes 2025 Annual Report and Sets June AGM Date
Company AnnouncementsPoolbeg Pharma Publishes 2025 Annual Report and Sets June AGM Date
20h ago
Poolbeg Pharma Signals Momentum Ahead of 2026 Data
PremiumCompany Announcements
Poolbeg Pharma Signals Momentum Ahead of 2026 Data
3d ago
Poolbeg Pharma advances POLB 001 and obesity pipeline on solid 2025 funding base
PremiumCompany Announcements
Poolbeg Pharma advances POLB 001 and obesity pipeline on solid 2025 funding base
10d ago
Poolbeg wins UK trial clearance as POLB 001 tipped for multi‑billion‑dollar CRS market
PremiumCompany Announcements
Poolbeg wins UK trial clearance as POLB 001 tipped for multi‑billion‑dollar CRS market
23d ago
Poolbeg wins first cancer CRS patent for POLB 001 in Australia
PremiumCompany Announcements
Poolbeg wins first cancer CRS patent for POLB 001 in Australia
1M ago
Poolbeg Pharma adds CAR-T veteran Kilcoyne to advisory board to bolster POLB 001 push
PremiumCompany AnnouncementsPoolbeg Pharma adds CAR-T veteran Kilcoyne to advisory board to bolster POLB 001 push
2M ago
Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
Premium
Company Announcements
Poolbeg Pharma bolsters case for POLB 001 with positive peer‑reviewed trial data
3M ago
Poolbeg Pharma Increases Share Capital After Option Exercises
Premium
Company Announcements
Poolbeg Pharma Increases Share Capital After Option Exercises
3M ago
Poolbeg Pharma Anticipates Clinical Breakthroughs Following a Year of Progress in 2025
PremiumCompany Announcements
Poolbeg Pharma Anticipates Clinical Breakthroughs Following a Year of Progress in 2025
5M ago
Poolbeg Pharma Leads in Groundbreaking Cancer Immunotherapy Research
PremiumCompany Announcements
Poolbeg Pharma Leads in Groundbreaking Cancer Immunotherapy Research
5M ago
Poolbeg Pharma Secures European Patent for POLB 001
PremiumCompany Announcements
Poolbeg Pharma Secures European Patent for POLB 001
6M ago
Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials
PremiumCompany Announcements
Poolbeg Pharma Reports Strong Interim Results and Advances Key Clinical Trials
7M ago
Poolbeg Pharma Advances POLB 001 Trial with Key Partnership and Drug Supply
PremiumCompany AnnouncementsPoolbeg Pharma Advances POLB 001 Trial with Key Partnership and Drug Supply
7M ago
Poolbeg Pharma Announces Change in Voting Rights Structure
Premium
Company Announcements
Poolbeg Pharma Announces Change in Voting Rights Structure
10M ago
Roaring Waters Capital Acquires 5.74% Stake in Poolbeg Pharma
Premium
Company Announcements
Roaring Waters Capital Acquires 5.74% Stake in Poolbeg Pharma
11M ago
Poolbeg Pharma’s Executive Chair Increases Stake in Fundraising Effort
PremiumCompany Announcements
Poolbeg Pharma’s Executive Chair Increases Stake in Fundraising Effort
11M ago
Poolbeg Pharma Secures Shareholder Approval and Expands Capital
PremiumCompany Announcements
Poolbeg Pharma Secures Shareholder Approval and Expands Capital
11M ago
Poolbeg Pharma’s POLB 001 Receives FDA Orphan Drug Designation
PremiumCompany Announcements
Poolbeg Pharma’s POLB 001 Receives FDA Orphan Drug Designation
12M ago
Poolbeg Pharma Releases Annual Report and Announces Fundraising Initiative
PremiumCompany Announcements
Poolbeg Pharma Releases Annual Report and Announces Fundraising Initiative
12M ago
Poolbeg Pharma Raises £4.865 Million to Advance Clinical Trials
PremiumCompany AnnouncementsPoolbeg Pharma Raises £4.865 Million to Advance Clinical Trials
12M ago
Poolbeg Pharma Expands BookBuild Offer Amid Strong Demand
Premium
Company Announcements
Poolbeg Pharma Expands BookBuild Offer Amid Strong Demand
12M ago
Poolbeg Pharma Raises £4.715 Million to Advance Clinical Trials
Premium
Company Announcements
Poolbeg Pharma Raises £4.715 Million to Advance Clinical Trials
12M ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >